These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21453227)

  • 1. Severe hepatitis C virus recurrence is nearly universal after donation after cardiac death liver transplant.
    Ortiz J; Feyssa EL; Parsikia A; Azhar A; Hashemi N; Campos S; Khanmoradi K; Zaki R; Balasubramanian M; Araya V
    Exp Clin Transplant; 2011 Apr; 9(2):105-12. PubMed ID: 21453227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts.
    Hernandez-Alejandro R; Croome KP; Quan D; Mawardi M; Chandok N; Dale C; McAlister V; Levstik MA; Wall W; Marotta P
    Transplantation; 2011 Sep; 92(6):686-9. PubMed ID: 21832962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
    Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M; Prieto M; Palau A; Rayón JM; Carrasco D; Juan FS; López-Labrador FX; Moreno R; Mir J; Berenguer J
    Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus 6 in donor biopsies associated with the incidence of clinical cytomegalovirus disease and hepatitis C virus recurrence.
    Guardia AC; Stucchi RS; Sampaio AM; Milan A; Costa SC; Pavan CR; Boin Ide F
    Int J Infect Dis; 2012 Feb; 16(2):e124-9. PubMed ID: 22178541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival.
    Hong JC; Yersiz H; Kositamongkol P; Xia VW; Kaldas FM; Petrowsky H; Farmer DG; Lipshutz G; Markovic D; Hiatt JR; Busuttil RW
    Arch Surg; 2011 Sep; 146(9):1017-23. PubMed ID: 21930997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donation after cardiac death organs for patients with hepatitis C virus: are we rolling the dice, or are they just as good as any?
    Bunchorntavakul C; Reddy KR
    Liver Transpl; 2011 Jun; 17(6):625-7. PubMed ID: 21491581
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of extended criteria donors in hepatitis C virus-positive recipients.
    Berenguer M
    Liver Transpl; 2008 Oct; 14 Suppl 2():S45-50. PubMed ID: 18825715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Course of the recurrence of hepatitis C virus infection after liver transplantation].
    Gugenheim J; Baldini E; Ouzan D; Mazza D; Saint-Paul MC; Goubaux B; Mouiel J
    Gastroenterol Clin Biol; 1996; 20(10):730-5. PubMed ID: 8991141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience.
    Grewal HP; Willingham DL; Nguyen J; Hewitt WR; Taner BC; Cornell D; Rosser BG; Keaveny AP; Aranda-Michel J; Satyanarayana R; Harnois D; Dickson RC; Kramer DJ; Hughes CB
    Liver Transpl; 2009 Sep; 15(9):1028-35. PubMed ID: 19718636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.